Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Notch Partners in the Long Journey of T-ALL Pathogenesis.

International journal of molecular sciences - 10 Jan 2023

Toribio María Luisa, González-García Sara

Abstract excerpt

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological disease that arises from the oncogenic transformation of developing T cells during T-lymphopoiesis. Although T-ALL prognosis has improved markedly in recent years, relapsing and refractory patients with dismal outcomes still represent a major clinical issue. Consequently, understanding the pathological mechanisms that lead to the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Cancer-related gene regulation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Epigenetics and DNA Methylation

Share to Mutation

Share to Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Share to Receptor, Notch1

Share to Signal Transduction

Source

Open in PubMed Open full text

Identifiers

PMID: 36674902
DOI: 10.3390/ijms24021383
PMCID: PMC9866461

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Notch Partners in the Long Journey of T-ALL Pathogenesis.PMID 36674902Read ↗

Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia.Semantic proximity Read ↗

Friend or foe: can activating mutations in NOTCH1 contribute to a favorable treatment outcome in patients with T-ALL?Semantic proximity Read ↗

Decoding NOTCH1: From T-Cell Development Guardian to Driver of Pediatric T-Cell Lymphoblastic Lymphoma.Semantic proximity Read ↗

Notch in T-ALL: new players in a complex diseaseSemantic proximity Read ↗

[Research advance on the pathogenesis of T-ALL induced by notch 1 activating mutations].Semantic proximity Read ↗

Two Faces of NOTCH1 in Childhood Lymphoblastic T-Cell Neoplasia: Prognostic Divergence of Mutational and Structural Aberrations.Semantic proximity Read ↗

Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think.Semantic proximity Read ↗

Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia ProgressionSemantic proximity Read ↗

Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies.Semantic proximity Read ↗

Notch signaling in T-cell acute lymphoblastic leukemia.Semantic proximity Read ↗

The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia.Semantic proximity Read ↗

MYC in T-cell acute lymphoblastic leukemia: functional implications and targeted strategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.